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Abstract 
There is substantial interest in exploring antibiotic alternatives with a new mode 
of action due to the increasing rates of bacterial resistance against current antibiotics. 
Antimicrobial peptides (AMPs) may take up the battle against bacteria in the future 
because as a result of their membrane-lysis mechanism, it is more difficult for bacteria to 
develop resistance against AMPs. Although AMPs could preferentially bind to and 
disrupt negatively charged bacterial membranes through electrostatic and hydrophobic 
interactions, there is still a great need to further increase the potency and selective 
toxicity towards bacteria for clinical applications. Herein, we present two strategies to 
improve the selectivity: light activation and environment-responsive moiety 
incorporation. Along the way, we also explored the effect of structure stabilization on 
AMPs action. A well-characterized antimicrobial peptide magainin 2 (mag2) was used as 
a prototype. Chemical manipulations of mag2 sequence were achieved by incorporation 
of unnatural amino acids. The selectivity was then tested on liposomes as a membrane 
model, as well as on bacterial cells and human red blood cells (hRBCs). Different extents 
of selectivity enhancement were observed from the modified peptides, and within the 
attempts to illustrate these results, we have gained useful information revealing the 
membrane-lysis mechanism, which may help us to rationally design and engineer AMPs 
as therapeutic drugs in the future. 
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Chapter 1: Introduction 
 
1.1 Global problem of antibiotic resistance 
Since their discovery, antibiotics have been the most useful weapons in fighting 
bacterial infections throughout the world. For example, penicillin, developed by 
Alexander Fleming in 1928 and once called a “miracle drug”, has defeated many once-
fatal bacterial infections and saved countless lives. However, it is a natural ability of 
bacteria to develop resistance against antibiotics, and the process of antibiotic resistance 
development has even been accelerated by the indiscriminate use of antibiotics in farm 
animals as well as people. According to the data from World Health Organization 
(WHO), every year in the European Union alone, about 25,000 patients die because of 
serious resistant bacterial infections acquired in hospitals. Because of this continuously 
growing problem, the WHO has set antibiotic resistance as the theme of World Health 
Day 2011 and called on the whole society to take action on regulation of proper 
antibiotics use and more importantly, exploration of new antibiotic medicines.  
This worldwide problem has thus stimulated the interest in developing 
alternatives for traditional antibiotics, especially those with the ability of bypassing 
current resistance mechanism. Ideally, these alternatives should be as natural as possible, 
with a wide range of action over several pathogens, easy to produce, and not prone to 
induce resistance1. Accumulated studies have proven that antimicrobial peptides (AMPs), 
isolated from a wide range of organisms and species from bacteria to humans, might 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  Zasloff, M., Antimicrobial peptides of multicellular organisms. Nature 2002, 415, 389-395	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	  
serve as promising replacements for eliminating pathogenic bacteria that are increasingly 
resistant to current antibiotic treatment. 
 
1.2 Antimicrobial peptides as an alternative to antibiotics 
Antimicrobial peptides (AMPs) are evolutionarily conserved components of 
organisms and are found among all types of life2. As effectors of innate immunity, AMPs 
directly kill a broad spectrum of microbes, including Gram-positive and Gram-negative 
bacteria, fungi, and certain viruses3. Since the first class of antibacterial peptides, 
cecropins were identified by Steiner 19814, the number of AMPs discovered has 
increased at a rapid pace. By August 2011, more than 1700 of AMPs have been identified 
according to the Antimicrobial Peptides Database (APD: 
http://aps.unmc.edu/AP/main.php). Despite the diversity of peptide sequence, AMPs have 
several properties in common. Most AMPs are short in length with 5 to 40 amino acid 
residues. Generally, AMPs are amphipathic, which enables them to selectively interact 
with and disrupt lipid membranes. The largest group of AMPs contains cationic peptides 
widely distributed in animals and people. The positive charges are usually provided by 
Lys and Arg, along with ~30% or more hydrophobic residues such as Trp and Phe.  
Two key features of AMPs contribute to their potential as antibiotics alternatives5. 
(1) It is much less likely for bacteria to develop resistance against AMPs because of their 
distinctive mechanism of action. (2) AMPs could selectively target and kill bacterial 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	  Marshall, S.H. Electronic Journal of Biotechnology 2003, 6, 271-284.	  3	  Gomesa, V.M.; Carvalhoa, A.O.; Cunhab, M. Da; Kellera, M.N.; Jr.c, C. Bloch; Deolindod, P.; Alvesd, 
E.W. Toxicon 2005, 45, 817–827. 4	  Steiner, H.; Hultmark, D.; Engstro¨m, A.; Bennich, H.; Boman, H.G. Nature 1981, 292, 246–248.	  
5 Matsuzaki, K. Biochimica et Biophysica Acta 1999, 1462, 1-10. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  3	  
cells. 
 
1.3 Mechanism of antimicrobial action 
Although the detailed mechanism of AMPs action may vary among different 
peptides, the membrane-targeting mechanism is the most conserved killing mechanism of 
AMPs. There is a general mechanism – the Shai-Matsuzaki-Huang (SMH) model (Figure 
1) that explains the activity of most AMPs6,7. To simplify this process, the mechanism 
can be divided into two steps. Firstly, the peptide will partition into the membrane-water 
interface with concomitant folding to afford an amphipathic structure. A combination of 
electrostatic forces and hydrophobicity drives the association between peptide and 
membrane, and determines the binding affinity of peptides. The second step involves 
membrane permeabilization or on-membrane action of the bound peptides, of which the 
molecular events remain vaguely defined. For most AMPs we are interested in, there is a 
threshold peptide to lipid ratio P/L*8. When P/L is below P/L*, peptides will impose 
positive curvature strain on the membrane by expanding the polar head group region to 
form the ‘toroidal’ pore, and peptides can translocate into the inner leaflet upon 
disintegration of the pore as shown in b-d of the SMH model (Fig. 1)9. As P/L increases 
above P/L*, stable pores are detected in the membrane10, or complete disruption of the 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  6	  Yang, L.; Weiss, T. M.; Lehrer, R. I. & Huang, H. W. Biophys. J. 2000, 79, 2002-2009. 7	  Shai, Y. Biochim. Biophys. Acta 1999, 1462, 55-70.	  8 Huang, H.W. Biochemistry, 2000, 39, 139-145 9 Matsuzaki, K.; Nakamura, A.; Murase, O.; Sugishita, K.; Fujii, N.; Miyajima, K. Biochemistry, 1997, 36, 
2104-2111 10 Huang, H.W. Biochimica et Biophysica Acta 2006, 1758, 1292-1302	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  4	  
membrane in a detergent-like way happens for a few peptides11,12(d-f in Fig. 1).  
Additionally, hypotheses have been proposed to explain the mechanisms by 
which peptides kill target cells other than membrane lysis; such hypotheses include 
induction of hydrolases which degrade the cell wall, disturbance of membrane functions, 
and damage to crucial intracellular targets after internalization of the peptide1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. The Shai-Matsuzaki-Huang model of the mechanism of antimicrobial action 
(adapted from [1]) 
Bacteria can readily develop resistance against traditional antibiotics; however, it 
is much harder for them to build resistance against AMPs. Antibiotics are designed to 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  11	  Shai, Y. Biopolymers 2002, 66, 236-248.  12	  Bechinger, B.; Lohner, K. BBA Biomembranes 2006, 1758, 1529-1539	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fight bacteria by targeting specific parts of the bacteria’s structure or cellular machinery. 
There are four major mechanisms (Fig. 2) that bacteria exhibit resistance against 
antibiotics13: altering the target site to which antibiotics bind; upregulating pumps that 
expel antibiotics from the cell; producing enzymes that inactivate or modify antibiotics; 
producing an alternative target that “bypasses” the effect of antibiotics. The rapid 
reproduction of bacteria (as little as 20 min) and the steady evolution of resistant bacteria 
have resulted in a situation that almost all antibiotics have lost their effectiveness against 
targeted bacteria over time. For example, in 1947-only four years after penicillin started 
being mass-produced, Staphylococcus aureus was found to be one of the bacteria in 
which penicillin resistance was developed. Now nearly all strains of Staphylococcus 
aureus in the United States are resistant to penicillin, and since 1996, strains of S. aureus 
have been reported to be decreasingly susceptible to vancomycin, which has been the 
only effective treatment left.  
One the other hand, because the target of AMPs is the bacterial membrane, to 
avoid such attack, bacteria will have to change their membrane composition, lipid 
arrangements, which is probably a “costly” way for most bacteria1.  AMPs have remained 
effective against bacterial infections for 108 years, despite their continual presence in the 
bacterial environment, which could be a strong indication that the resistance of bacteria 
against AMPs is difficult to evolve in the short term1. Additionally, the diversity of 
AMPs sequence and structure, and the varied modes of action might impede the 
development of resistance. This feature plays an important role in the determination of 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  13	  Hawkey, P.H. BMJ, 1998, 317, 657-660 
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AMPs as attractive antibiotic alternatives and encourages exploration of new therapeutic 
drugs using AMPs as a model.   
 
Figure 2. Four major biochemical mechanisms of antibiotic resistance (Adapted from [13]) 
  
1.4 Selective toxicity against bacteria 
 Besides their unique mechanism of action, the intrinsic selective toxicity of 
AMPs against bacteria is another key feature that makes AMPs stand out as antibiotic 
drugs. The difference in the membrane composition between eukaryotic and prokaryotic 
cells accounts for the ability of AMPs to kill bacteria selectively. For mammalian cells, 
the outer leaflet is composed principally of phosphatidylcholine (45-55%) and 
sphingomyelin, which are both neutral, zwitterionic phospholipids. Also ~30% of the 
neutral sterol cholesterol exist in the mammalian plasma membrane outer leaflets. In 
contrast, the typical bacterial phospholipids in the outer leaflet of the bilayer are 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  7	  
negatively charged lipids (20-25%) such as cardiolipin (CL) and phosphatidylglycerol 
(PG) with phosphatidylethanolamine as the zwitterionic component.  
       
 
 
 
Figure 3. Molecular basis for membrane discrimination by AMPs (Adapted from [5]) 
 
There are two main interactions between peptides and bacterial membranes: 
hydrophobic interactions between the non-polar amino acids and the hydrophobic core of 
the membrane5, and electrostatic interactions between cationic amino acid residues and 
negatively charged phospholipid headgroups. The hydrophobicities of AMPs are usually 
too low to effectively interact with neutral membranes, avoiding toxicity towards 
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mammalian cells, thus electrostatic interactions play a regulatory role in differentiating 
microorganisms from eukaryotic cells (Figure 3). 
 
1.5 Experimental goals 
For AMPs to fulfill their therapeutic promise as the next generation of antibiotic 
drugs, more studies are needed to improve their properties such as enhanced selectivity 
(reduce the potential for unwanted toxicity) and increased antimicrobial activity. 
Additionally, detailed information about their mechanisms of action is meaningful 
towards rational design and engineering of AMPs. Here we present three related projects 
aiming to enhance the selectivity while at the same time, obtaining useful information 
towards elucidation of the mechanism.  
 
Chapter 2: Experiments and Results 
 
2.1 Overview of magainin 2 
Magainins, first discovered in the skin of Xenopus laevis14,15, are a series of 
cationic peptides with 21 to 27 amino acid residues that create an amphiphatic secondary 
structure. Magainins show a broad spectrum of antimicrobial activity, killing not only 
Gram-negative and –positive bacteria, but also fungi and protozoa. As a 23-residue 
cationic antimicrobial peptide (GIGKFLHSAKKFGKAFVGEIMNS), Magainin 2 
(Mag2) might be the most studied among all the AMPs. It is unstructured in aqueous 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  14 Zasloff,M. Proc.Natl.Acad.Sci.1987, 84, 5449-5453.  15	  Matsuzaki, K. Biochim.Biophys.Acta, 1998, 1376, 391-400	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  9	  
solution but forms an α-helix upon contact with the membrane, characterized by 
separated cationic and hydrophobic faces. Fig. 4 is a helical wheel projection of mag2 
clearly showing a hydrophobic face and hydrophilic face separated from each other16. 
The three Phe residues are important components of the hydrophobic face, and four Lys 
residues contribute to the overall positive charge of the peptide. 
 
 
Figure 4. Helical wheel projection of Mag2. Dark shading, acidic residues; light shading, 
hydrophobic resiudes; and open symbols, hydrophilic residues (adapted from [16]) 
 
Extensive studies on the development of potent drugs based on mag2 have been 
performed, such as structure-activity relationship17,18 ,19 ,20 ,21 ,22 ,23. Various structural 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  16	  Gregory S.M.; Pokorny A.; Almeida P.F. Biophys J. 2009, 96, 116-31. 	  
17  Zasloff, M.; Martin, B.; Chen, H. Proc. Natl. Acad. Sci., 1988, 85, 910-913 
18  Chen, H.; Brown, J.H.; Morell, J.L.; Huang, C.M. FEB, 1988, 236, 462-466 
19 Matsuzaki, K.; Sugishita, K.; Harada, M.; Fujii, N.; Miyajima, K. Biochimica et Biophysica Acta 1997, 
1327, 119-130 
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parameters such as α-helicity, net positive charge, hydrophobicity and hydrophobic 
moment are related to mag2 antimicrobial activity.  The importance of an amphiphathic 
α-helical structure and a net positive charge for antimicrobial activity has been 
emphasized by these studies.  Replacement of a low helix propensity amino acid with a 
high propensity Ala not only increased the α-helicity, but also antimicrobial activity18. 
An increase in peptide positive charge enhanced the bactericidal activity19, 21. 
Hydrophobicity enhancement is also a method of intensifying the antimicrobial potency, 
however, this type of method simultaneously raised the toxicity22.  
 
2.2 Photocontrolling magainin 2 antimicrobial activity 
 
2.2.1 Background and experimental design 
Light regulation of bio-systems is of considerable interest because light can be 
readily tuned and focused, and spatial and temporal control can be utilized to provide 
“on-command” activation. Caged bioactive molecules could be activated by release of a 
chemical blocking group with a light pulse as the external stimuli24. However, this 
process is irreversible and people are more interested in utilizing reversible photo-control 
over bioactive compounds. To this end, an azobenzene-based cross-linker was 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
20 Cuervo, J.H.; Rodriguez, B.; Houghten, R.A. Peptide research, 1988, 1, 81-86 
21 Bessalle, R.; Haas, H.; Goria, A.; Shalit, I.; Fridkin, M.; Antimicrobial Angents and Chemotherapy, 1992, 
36, 313-317 
22 Dathe, M.; Wieprecht, T.; Nikolenko, H.; Handel, L.; Maloy, W.L.; MacDonald, D.L.; Beyermann, M.; 
Bienert, M. FEBS Letters, 1997, 403, 208-212 
23 Maloy, W.L.; Kari, U.P. Biopolymers, 1995, 37, 105-122	  
24	  Nguyen, A.; Rothman, D.M.; Stehn, J.; Imperiali, B.; Kramer, R.H. Nat. Biotechnol. 2004, 22, 993-1000	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successfully applied to optically control peptide helix content in a reversible manner25. 
Also, incorporation of the photoisomerizable amino acid phenyl-azophenylalanine (PAP) 
into enzyme structures has been utilized to create photoswitching enzyme activities26, 27. 
Azobenzene can be switched between trans and cis conformations with appropriate 
wavelengths of light (Figure 5). Irradiation with ~340nm light converts azobenzene from 
trans to cis isomer; the cis conformation slowly relaxs back to the trans conformation in 
the dark [t1/2≈3 days]28 or upon irradiation at ≥420nm29. Because of significant difference 
between the two isomers in geometry and dipole moments, remarkable effects have been 
observed with azobenzene-modified peptides and proteins, including photoinduced helix-
coil transitions, helix sense reversal, and aggregation/disaggregation30. Inspired by these 
studies, we incorporated PAP into the sequence of mag2. We hypothesized that the 
cis/trans isomerization of azobenzene could be utilized to tune the membrane-lytic 
activity of Mag2.  
 
 
 
 
Figure 5. Isomerization of azobenzene moiety 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  25	  Woolley, G.A. Acc. Chem. Res. 2005, 38, 486-493	  26	  Willner, I.; Rubin, S. and Riklin, A. J. Am. Chem. Soc. 1991, 113,3321. 	  27	  Liu, D.; Karanicolas, J.; Yu, C.; Zhang, Z.; Woolley, G.A. Bioorg. Med. Chem. Lett. 1997, 7, 2677-2680	  28	  Zhang, J.; James, D. A.; Woolley, G.A. J. Peptides Res.1999, 53, 560-56. 29	  Zimmerman, G.; Chow, L.Y.; Paik, U.J., J. Am. Chem. Soc. 1958, 80, 3528-3531	  30	  Pieroni, O.; Fissi, A.; Angelini, N.; Lenci, F., Photoresponsive polypeptides. Acc. Chem. Res. 2001, 34, 
9-17 	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2.2.2 Results and Discussions 
To test this hypothesis, we synthesized a mag2 variant (F12PAP-mag2) with 
Phe12 replaced by PAP. Phe12 is at the center of the peptide sequence, so when the 
peptide forms an α-helix upon association with the membrane, the azobenzene moiety 
will be located in the center of helical structure which will allow for maximum structural 
change with the cis/trans isomerization. We first studied the reversible trans-to-cis 
photoisomerization under irradiation with light of 337nm (Fig. 6), and the obtained cis-
isomer had completely different UV-vis spectra from its corresponding trans counterpart. 
The photostationary equilibrium (cis/trans=80:20, evaluated by LC-MS) was reached 
within 1 hr. Alternatively, when exposed to light of longer wavelength (>400nm), the cis 
form was converted to predominantly the trans conformation.  
 
 
 
Figure 6. Absorption spectra of F12PAP-Mag 2 (4µM) in 3M GdnCl, 10mM TES, 100mM 
sodium citrate, pH 7.0 buffer: irradiation at 337 nm for 1 hr converted the trans isomer to the 
cis isomer 
	  	   	  
trans isomer 
cis isomer 
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Next, we investigated the membrane-lytic activity of F12PAP-mag2 against large 
unilamellar vesicles (LUVs) by utilizing an optimized liposome leakage assay with Tb3+ 
encapsulated vesicles31, 32 (see Materials and Methods, Scheme S9). 
 Peptides were titrated into solutions containing dipicolinic acid (DPA) and 
negatively charged LUVs (POPC/POPG 1/1) encapsulating with 50 mM TbCl3 inside the 
vesicles. Membrane lysis by mag2 variants caused the leakage of Tb3+, which then 
formed luminescent complexes with the DPA in the solution. F12PAP-mag2 was highly 
potent in lysing LUVs when it adopted the trans conformation (Fig. 7), and irradiation at 
337nm afforded predominantly the cis isomers that showed around a 5-6 fold decrease in 
membrane-lytic activity. The incomplete trans to cis transition may contribute to the 
observed activity of “cis” isomer, and the difference in membrane-lytic activity between 
trans and cis peptides may be even larger by taking this into consideration. Notably, the 
membrane-lytic activity could be fully recovered either by irradiation at a longer 
wavelength (>400nm) or dark incubation.  
 
 
 
 
 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  31	  Rathinakumar, R.; Wimley,W.C. J.Am.Chem.Soc., 2008, 130, 9849-9858.	  32	  Rausch, J.M.; Wimley,W.C. Anal.Biochem., 2001, 293, 258-263	  
Figure 7. Photoswitching modulates mag2 
membrane permeabilization. Isomerization 
of azobenzene elicites a significant change in 
membrane lysis. This experiment was 
performed with 2 µM peptide and 500 µM 
LUVs made of POPC/POPG 1/1 at room 
temperature with stirring. (Data presented is 
average of three measurements) 	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Antimicrobial activities of AMPs are usually modified in two aspects 
corresponding to the two steps of the SMH model: binding affinity and membrane-
disturbing ability of bound peptides. One of them or both could be altered upon 
azobenzene photoisomerization.  
To address this question, we incorporated a dansyl (DNS) group in addition to the 
azobenzene group into mag2 to obtain another variant F5DNS-F12PAP-mag2 (see 
Materials and Methods, Scheme S8). Dansyl was used as an environment-sensitive 
fluorescent probe to detect the association between F5DNS-F12PAP-mag2 and lipid 
bilayers. When the peptides labeled with dansyl bind to membrane, dansyl fluorescence is 
blue-shifted from 545nm to 503nm, with the intensity being enhanced around 10-fold. 
Similar to F12PAP-mag2, trans and cis peptides of this variant showed a difference in 
membrane-lytic activity (see Materials and Methods, Fig. S1).  
 
 
 Figure 8. Characterization of binding affinities for F5DNS-F12PAP-mag2. This 
experiment was performed with 2 µΜ peptide and varying concentrations of lipids. The graph 
was plotted with dansyl fluorescence at 502 nm versus L/P ratio. Trans F5DNS-F12PAP- mag 
2, KD, app = 39; Cis F5DNS-F12PAP- Mag 2, KD, app = 36.  	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In the binding affinity experiment (Fig. 8), 2 µM peptide and varying 
concentrations of lipids were used and it turned out that binding affinities were 
comparable for these two peptide isomers towards LUVs (POPC/POPG 1/1). 
Additionally, under the leakage assay conditions in Fig. 7 (P/L = 1/250), all peptide 
molecules were bound for both isomers based on the apparent Kd values, indicating that 
the binding affinity did not account for the lytic activity difference. 
We then characterized the secondary structures of both isomers (Fig. 9) in small 
unilamellar vesicles (SUVs) made of POPC/ POPG 1/1 with the P/L ratio of 1/250 to 
make sure an altered secondary structure of the bound peptides was not the cause of the 
lytic difference. The obtained CD spectra for the trans and cis isomers of F5DNS-
F12PAP-mag2 showed identical α-helix structures, eliminating the possibility that 
secondary structure propensities afforded the difference in membrane-lytic activity. 
 
    
 
Figure 9. CD spectra of F5DNS-F12PAP-mag2 (peptide concentration 10 µΜ) in 
the presence of POPC/POPG 1/1 SUVs (lipid concentration=2.5 mM, P/L = 1/250). 
Black curve, trans isomer; red curve, cis isomer. 
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With both binding affinity and secondary structure excluded, the difference in 
membrane-lytic activity has to stem from the different peptide membrane-disturbing 
ability. As mentioned in the introduction (Fig. 1), three mechanisms are related to 
membrane-disturbing abilities: transient or permanent pore formation or complete 
membrane disruption. 
Dynamic Light Scattering (DLS) measurements were first taken to monitor the 
integrity of LUVs with peptide addition, and no difference in vesicle size and dispersion 
implied that the vesicles were intact, eliminating the complete membrane disruption 
mechanism. Inspired by Matsuzaki’s study about mag231, we used a fluorescence-
quenching method to detect if transient or permanent pores formed under our 
experimental conditions (see Materials and Methods, Scheme S11). In this experiment, 
symmetrically NBD-PE labeled LUVs (POPC/POPG/NBD-PE = 1/1/0.005) were 
incubated at 30 °C with peptides for 2 hr when membrane lysis almost reached the 
plateau. Dithionite was then added to reduce NBD groups available.  
In Matsuzaki’s work, inner leaflet NBD-PE labeled LUVs (egg PC/egg PG/NBD-
PE = 1/1/0.005) have been used to prove that 12-Trp magainin 2 induced the coupled 
transbilayer transport ions and lipids by forming a short-lived pore during peptide 
translocation33. If our peptides induce transient pore formation in a similar lipid flip-flop 
coupled manner, then when leakage reaches the plateau, most of the peptide translocation 
should deactivate and the pores dissociate, leaving almost no chance for dithionite 
reduction of NBD groups located in the inner leaflet. If permanent pore form, however, a 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  33	  Matsuzaki, K.; Murase, O.; Fujii, N.; Miyajima, K. Biochemistry, 1996, 35, 11361-11368	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certain percentage of inner leaflet NBD quenching should be expected because dithionite 
could enter the inside through the pores. 
Two control experiments were done to validate this method. Firstly, addition of 
dithionite into the LUVs with no peptides resulted in complete fluorescence quenching of 
NBD groups on the outer leaflet (0% quenching of NBD groups in the inner leaflet), 
while dithionite addition into the LUVs incubated with 0.1% Triton X-100 resulted in 
complete quenching of all NBD groups (100% quenching of NBD groups in the inner 
leaflet).  
From Fig. 10, we could tell that at low peptide concentration (2 µM), no 
permanent pores formed and only the fluorescence of NBD groups in the outer leaflet 
was quenched; while at concentrations as high as 9 µM, stable pores formed and 
complete NBD fluorescence quenching occurred (F5W-F12PAP-mag2 has similar 
properties as F5DNS-F12PAP-mag2). 
 
Figure 10. NBD fluorescence-quenching assay with trans F5W-F12PAP-mag2. 1 mM 
POPC/POPG 1/1 LUVs (symmetrically labeled with 0.25% NBD-PE) were incubated with 2 
and 9 µM peptides at 30 °C. Dithionite was added 2 hr later (final concentration 10 mM), and 
addition of 10% Triton X made all NBD lipids accessible to dithionite 
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A distinctive feature of transient pore formation is peptide translocation. It is 
highly likely that the trans peptide induces a higher percentage of peptide translocation 
coupled with a larger percentage of Tb3+ leakage. To prove this hyphothesis, a modified 
enzyme digestion method was adopted to measure the fraction of peptide translocated31 
(scheme 1).  
 
Scheme 1. Enzyme digestion assay 
 
Trypsin is an enzyme that effectively hydrolyzes mag2. F5DNS-F12PAP-mag2 
and the LUVs (POPC/POPG/NBD-PE = 1/1/0.005) were used in this method. Addition 
of this peptide into the LUVs resulted in rapid binding of the peptide to the membrane 
and enhanced fluorescence intensity of dansyl group Fm. After 2 hrs incubation, trypsin 
was added to selectively digest the peptide molecules located in the outer monolayer 
while leaving the translocated peptides intact. The digested peptide fragments were 
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desorbed from the membrane back into the buffer, leading to a decrease in fluorescence 
intensity of dansyl. The resulting fluorescence intensity Ft was a mixture of fluorescence 
intensity from peptide translocated and digested peptide in the solution. Incubation of 
peptides with trypsin first followed by LUVs addition afforded complete digestion of 
peptide molecules by trypsin and no binding to the membrane, which created Fw. Based 
on Fw, Fm, Ft, we were able to calculate the percentage as well as amount of peptide 
translocated for both isomers (Fig. 11). 
 
 
 
 
 
 
 
 
 
Figure 11. Calculation of percentage of peptide translocation 
                                                         1 µM trans+500 µM lipids                 1 µM cis+500 µM lipids 
Percentage of translocation                                     33%                                         7% 
Percentage of leakage                                             32%                                         9% 
 
Table 1. Peptide translocation measured by enzyme digestion assay. For each experiment, 
1 µM peptide was incubated with 0.5 mM LUVs at room temperature for 2 hrs, followed by 
trypsin treatment. Dansyl fluorescence was recorded before and after trypsin treatment, 
respectively. Data presented here are the average of duplicated samples  
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Data in Table 1 shows that under the same conditions, the trans-peptide induced a 
larger fraction of Tb3+ leakage as well as a higher percentage of peptide translocation 
than the cis-isomer did.  
Based on these results, we concluded that with same amount of bound peptides 
and similar secondary structures, the trans-peptide not only elicits a higher potency in 
membrane lysis compared with the cis-peptide, but also a higher degree of peptide 
translocation when P/L is lower than the threshold P/L* (we didn’t measure the exact 
value of P/L*, but it is very likely that the trans peptide has a much lower P/L* than the 
cis peptide does). By looking at the azobenzene structure, it is conceivable that the 
different membrane-lytic activity is due to the huge conformational difference between 
the two azobenzene isomers, and to be more specific, length difference. For trans 
azobenzne, the distance between two para carbons is 9.2 Å, while for cis azobenzene it 
decreases to 5.4 Å. To test this hypothesis, we designed a series of mag2 variants 
carrying side chains with varying length at the same position of azobenzene and all 
labeled with a dansyl group. These side chains are phenyl, biphenyl, and terphenyl with 
the distance between two para carbons being 2.8 Å, 7.2 Å, and 11.6 Å respectively (Fig. 
12, unnatural amino acid Fmoc-biphenyl-OH and Fmoc-terphenyl-OH were used). 
Binding affinities were characterized by the same method (Fig. 13a) and a leakage assay 
was carried out under conditions where all peptide molecules were bound to the 
membrane for all variants (Fig. 13b). 
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The diverse binding affinities can be attributed to the different hydrophobicities of 
the three side chains, while L/P ratio of 500/1 for the leakage assay guaranteed all peptide 
molecules were completely bound to the membrane for these variants. Thus it is 
reasonable to conclude that the observed difference in membrane lysis is due to the 
different in side chain length. With the longest side chain, F5DNS-F12terphenyl-mag2 
showed the highest potency and F5DNS-mag2 showed the lowest. This result confirmed 
our hypothesis that the side chain length plays a major role in determining the membrane-
lytic activity of mag2. Moreover, the membrane-lytic activities were measured under 
varied peptide concentrations against 500 µM LUVs (POPC/POPG 1/1) and an EC50 
obtained was 3.44 ± 0.06 µM, 1.37 ± 0.02 µM and 1.11 ± 0.02 µM for F5DNS-mag2, 
F5DNS-F12biphenyl-mag2 and F5DNS-F12terphenyl-mag2 respectively (see Materials 
and Methods, Fig. S2) 
 
 
Figure 12. Structures of F5DNS-mag2, F5DNS-F12biphenyl-mag2 and F5DNS-
F12terphenyl-mag2. 	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To elucidate this phenomenon, it is important to introduce ‘interfacial activity’34 
into our system. Interfacial activity is described as the ability of a molecule to bind to a 
membrane, partition into the membrane-water interface, and to alter the packing and 
organization of the lipids. When mag2 binds to the lipid bilayers, the hydrophobic region, 
mainly consisted of aromatic residues (phenyl, biphenyl and terphenyl), drives a deep 
perturbation into the lipid bilayers, and the nearby polar residues such as lysine promote 
the incursion of lipid polar groups deeper into the membrane, along with the polar 
residues of mag2. A more extended hydrophobic side chain would be able to perturb the 
membrane to a higher degree, due to a strengthened interaction between the hydrophobic 	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  Wimley, W.C. ACS Chem. Biol. 2010, 5, 905-917	  
Figure 13. Characterization of binding affinities and lytic activity of three mag2 mutants. 
a.) Binding affinity experiment was performed with 2 µM peptide and varying concentrations of 
lipids. The graph was plotted with dansyl fluorescence at 502 nm versus L/P ratio. F5DNS-
mag2, KD, app = 35; F5DNS-F12biphenyl-mag2, KD, app = 5; F5DNS-F12terphenyl-mag2, KD, app = 
2. b.) Three peptide mutants show increasing extent of membrane lysis with increased side chain 
length. This leakage assay was performed with 1 µM peptide and 500 µM LUVs made of POPC/ 
POPG 1/1 at room temperature under stirring. Data presented are the average of three 
measurements (standard deviations as absolute percentage were less than 8%)   	  
b.	  a.	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side chains and neighbor hydrophobic moieties. The extent of perturbation is coupled 
with peptide translocation and membrane-lytic activity as well. Here we propose the 
importance of side chain length in determining membrane lysis activity, which may shed 
light on design and engineering membrane-active peptides. However, there is still 
difficulty in rational and systematic engineering of such peptides because ‘interfacial 
activity’ is an integrated effect of peptide’s amphipathicity, balance between hydrophobic 
and polar residues, the potential to alter the packing and curvature of lipids.  
 
2.2.3 Conclusions 
In summary, we have incorporated a photolabile side chain into antimicrobial 
peptide mag2 and demonstrated photo-switchable membrane-lytic activity of this peptide. 
Unlike traditional modifications of binding affinity and secondary structure of the 
antimicrobial peptide, trans-cis isomerization alters peptide ‘interfacial activity’ coupled 
with membrane-lytic activity, upon which we could manipulate the peptide activity easily 
with light irradiation. In addition to that, our mechanistic study suggests that side chain 
length plays an important role in interfacial activity, while more studies are needed to 
gain a better understanding of it and direct rational design of membrane-active peptides.  
Finally, the incomplete photo-conversion of azobenzene between cis and trans 
isomers sets intrinsic limits on the degree of photomodulation of AMPs activity. By using 
other azobenzene derivatives that undergo high conversion from the trans to the cis 
isomer, we may be able to realize the complete “switch on and off” strategy.  Moreover, 
it is more beneficial if we could create a long-wavelength irradiation located in the 
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biological transparent spectral range (800-1000nm) with the capability of penetrating 
more deeply into the biological tissues. 
 
2.3 Enhancement of selective toxicity by environment-responsive residues 
 
2.3.1 Background and experimental design 
People have utilized environment-responsive residues in development of pH-
sensitive membrane-active peptides. Our group has successfully developed a ‘smart’ 
mag2 functionalized with tetrafluorotyrosine (f4Y) as effective pH sensor35. Three Phe 
residues at the hydrophobic face were replaced by f4Y, and because pKa of f4Y is 5.6, 
when the pH dropped from 7.0 to 5.0, the membrane-lytic activity of the mag2 variant 
went through a dramatic increase.  Here, pH was employed as the external stimuli to 
activate mag2. 
With the continuous effort in exploring the applications of environment-
responsive residues in AMPs, we tried to develop another ‘smart’ peptide that could only 
be activated upon contact with the negatively charged membrane. Fmoc-LHA-OH is an 
unnatural amino acid developed by our group with an environment-responsive LHA 
moiety (Fig. 14). The pKa of LHA is around 8 in aqueous solution (protonated-positively 
charged), and expected to be downshifted in a hydrophobic environment (deprotonated-
neutral). Replacement of 1-3 Phe residues in the hydrophobic face of mag2 with LHA 
group would strengthen the electrostatic interactions between mag2 and negatively 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  35 Wang, F.; Qin, L.; Wong, P.; Gao, J. Org. Lett. 2010, 13, 236-239 
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charged membrane due to the increased overall positive charge at pH 7, while it would 
decrease or even wipe out the binding of mag2 to neutral membranes because of 
decreased hydrophobic interactions. Thus the difference in binding affinities is amplified. 
Furthermore, once LHA-incorporated mag2 is bound to negatively charged membrane, 
LHA should be deprotonated in the hydrophobic environment and the membrane-lytic 
activity of mag2 should be restored. In summary, the selectivity of LHA incorporated 
mag2 variants would be enhanced due to the largely decreased or lost binding to neutral 
membrane, and the activity of mag2 could only be turned on when binding to negatively 
charge membrane. 
However, according to the measured pKa values of LHA moiety (Fig. 14, pKa 
measurement see Materials and Methods, Fig. S4, S5), different membranes (neutral, 
positive, and negative) influenced the pKa values quite differently. This was also 
observed in a published work measuring pKa of fluorescent pH indicators in different 
membranes36. The measured pKa of LHA moiety was around 8.2 in aqueous solution, 6.5 
in neutral membrane and 8.4 in negatively charged membrane.   
 
 
 
Figure 14. pKa change of LHA in  different environment 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  36 Fernandez, M.S.; Fromherz, P. The Journal of Physical Chemistry, 1977, 81 
O
NH
Environment pKa 
Water 8.2 
DPC micelles (Neutral) 6.5 
SDS micelles (Negatively charged) 8.4 
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Thus the major concern of this strategy lies in the fact that negatively charged 
membrane increases the pKa to such a large extent, and LHA would remain positively 
charged on negatively charged membranes, the membrane-lytic activity of the bound 
peptide could be sacrificed because of the broken amphiphathicity. Still, we were curious 
to find out if the enlarged binding affinity difference could result in enhanced selectivity 
at the price of possible activity loss. 
 
2.3.2 Results and Discussion 
Two mag2 variants were prepared: The single LHA substituted variant N-DNS-
F12LHA-mag2a and triple mutant N-DNS-TriLHA-mag2. Another peptide N-DNS-
mag2a was synthesized as a control. The binding affinities were evaluated based on 
dansyl fluorescence. 
  
 
 
 
 
 
 
 
Figure 15. Characterizationi of N-DNS-mag2a and N-DNS-F12LHA-mag2a binding 
affinities. This experiment was performed with 100 µΜ LUVs (POPC and POPC/POPG 1/1) 
and varying concentrations of peptides. The graph was plotted with dansyl fluorescence 
I502nm/I550nm versus peptide concentration.  
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In Fig. 15 for negatively charged LUVs (POPC/POPG 1/1), the binding affinities 
were comparable between these two peptides, however for neutral LUVs (POPC), 
binding affinity of the single LHA mutant was largely decreased because of loss of 
hydrophobic interactions.  Membrane-lytic activities were measured under varied peptide 
concentrations and EC50 was obtained for comparison. EC50 of the LHA single mutant 
was 2-fold higher than the control (N-DNS-mag2a) on the negatively charged membrane, 
and for neutral membrane, EC50  increased 4-fold, leading to a selectivity enhancement 
about 2-fold. There was moderate enhancement in cell-based assays, as shown in table 2. 
 
EC50 (µM) 
Peptide 
POPC LUVs 
POPC/POPG 1/1 
LUVs 
MIC (µg/ml) HC50 (µg/ml) 
N-DNS-mag2a 1.10±0.02 0.51±0.02 4 43 
N-DNS-F12LHA-mag2a 4.68±0.20 1.00±0.01 16 215 
N-DNS-TriLHA-mag2a Inactive Limited activity N/A N/A 
 
Table 2 Membrane-lytic, Antimicrobial and Hemolytic activities of LHA incorporated 
mag2. For membrane-lytic activity measurement, 0.1 mM LUVs were used for each experiment. 
 
 
For the triple mutant, there was almost no binding to neutral membrane (the 
maximum dansyl fluorescence peak stayed at 550 nm and no shift was observed). Out of 
our expectation, binding to negatively charged membrane was also very limited (Fig. 16). 
Moreover, limited membrane-lytic activity was observed for both LUVs (POPC/POPG 
1/1) and LUVs (POPC).  
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Based on our previous concern, it is conceivable that these LHA incorporated 
mag2 have lost part of the ability to fold into active α−helix after binding. CD 
experiments were then conducted to address this question.  
From CD measurements, all three peptides were able to fold into α−helices in 
PBS buffer with 50% TFE at both pH 7 and 9, indicating that the protonated and 
deprotonated LHA side chain caused no difference in the ability of mag2 folding. 
     For the single variant, it had similar binding affinity and α helicity on 
POPC/PCPG 1/1 membrane as the control peptide N-DNS-mag2a , however, EC50 was 2-
fold higher. The protonated LHA in the bound single mutant, compared to Phe in the 
control peptide, may disturb the interfacial activity of mag2 by placing a postively 
charged residue in the hydrophobic face.  
Figure 16. Characterizationi of N-DNS-mag2a and N-DNS-TriLHA-mag2a binding 
affinities. This experiment was performed with 100 µΜ LUVs (POPC and POPC/POPG 1/1) 
and varying concentrations of peptides. The graph was plotted with dansyl fluorescence 
I502nm/I550nm versus peptide concentration.  
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Given the slightly enhanced selectivity of the single variant (2-fold), the effect 
from enlarged binding affinity difference between neutral and negatively charged 
Figure 17. CD measurements of three mag2 variant in both SUVs (POPC/POPG 1/1) and 
50% TFE in PBS buffer  	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membrane is probably counteracted by the decreased membrane-disturbing ability of 
bound peptide on negatviely charged membrane. Moreover, since the measured pKa in 
neutral membrane is 6.5,  then the bound peptide on neutral membrane may be more 
potent (LHA deprotonated) than the bound peptide with positively charged LHA on 
negatviely charged membrane. This modification has an adverse effect on improving 
selectivity.    
    In SUVs (POPC/PCPG 1/1), the triple variant was mostly random coil at pH 7 
and showed moderately improved α helicity at pH 9. The main reason for the secondary 
structure loss at pH 7 was due to the poor binding to the negatively charged membrane 
and most of the peptide molecules remained in the aqeous solution. Compared to the 
single variant, it is even harder for the triple variant to fold into α-helix with three 
positively charged residues on the hydrophobic face. The strong electrostatic interactions 
between positively charged LHA and  negatively charged lipids may prevent the peptides 
from folding into correct α-helix. And this may explain why the triple variant has even 
lower binding affinity to negatively charged membrane than the single mutant does: the 
bound triple mutant peptides are unstructured on membrane and cover a larger surface 
than structured mag2 α-helix, leaving less space for more peptide to bind; the triple 
mutant has three more positive charges per peptide molecule than mag2 and the 
electrostatic interaction is saturated rapidly. 
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2.3.3 Conclusions 
 To conclude, we observed a small enhancement in selectivity (2-fold) by 
functionalizing mag2 with an environment-responsive LHA moiety. It is exciting to see a 
single amino acid replacement  at the hydrophobic face has a significant impact on 
peptide binding to neutral membranes. However, we underestimated the effect of 
different charged membranes on the pKa of the environment-responsive moiety and the 
following influence on peptide membrane-disturbing ability. It would be interesting to 
see if the triple mutant could fold into an α helix and induce membrane lysis with the 
help of a preinstalled secondary structure stabilizer.  
 
2.4 Side-chain staple facilitates on-membrane action of magainin 2 
 
2.4.1 Background and experimental design 
Stabilization of peptide α-helical structures via side-chain stapling has been 
successfully utilized in studies of protein-biomacromolecule interactions37,38. In the past 
decade, one of the most popular methods of helix stabilization has been the use of ring-
closing metathesis (RCM) to link the side chains at i and i+4 or i+7 positions39.  
Installation of the all-carbon cross-linking has been shown to increase both helical 
contents and peptide binding affinity, also remarkably decrease the rate of proteolysis. In 
addition to peptide cyclization through RCM, the use of the Huisgen Cu (I) catalyzed 1,3-	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  37	  Walensky, L.D.; Kung, A.L.; Escher, I.; Malia, T.J.; Barbuto, S.; Wright, R.D.; Wagner, G.; Verdine7, 
G.L.; Korsmeyer, S.J. Science 2004, 305, 1466-1470. 	  38	  Kajino, M.; Fujimoto, K.; Inouye, M. J.Am.Chem.Soc. 2011, 133, 656-659	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dipolar cycloaddition reaction has been reported40,41.  This click reaction is simple, mild 
and has high yields. Inspired by these accomplishments, we hypothesized that a side-
chain staple may also improve the interaction between mag2 and membranes because of 
the pre-organized secondary structures in aqueous solution, and even this side-chain 
stabilization could affect peptide on-membrane activity as well.  
 Besides, a side-chain staple might be a convenient tool for us to manipulate the 
membrane-lytic activity of AMPs by providing a pre-organized scaffold. For example, 
for the second project a side-chain staple may help the triple LHA mutant recover certain 
ability to fold into correct α helical structure; for the ‘interfacial activity’ study, we could 
study the most relevant factors towards optimization of ‘interfacial activity’ by 
systematically change the numbers, positions and arrangements of hydrophobic and polar 
residues on the basis of a strong pre-stabilized secondary structure, without worrying 
about these manipulations may disrupt the folding abilities a lot.  
 
2.4.2 Results and Discussion 
Considering the reported insolubility of peptides with a hydrophobic staple 
generated by RCM and expensive, toxic ruthenium based catalysts involved42, we chose 
the triazole stapling approach. To construct stapled mag2, we placed synthetic azide and 
alkyne modified amino acid at certain positions separately, and the triazole staple 
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  A dissertation submitted in partial fulfillment of the requirements for the degree of 
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spanning the i, i+4 positions was generated by click reaction (Fig. 18). Two variants were 
synthesized, each containing a distinctively localized cross-link (Fig. 18). A dansyl group 
was incorporated at the N-terminal of all peptides to evaluate binding abilities and C-
terminal amide was introduced to keep the total charge unchanged. For mag2a-1 and 
mag2a-1S, E19 was replaced with A to maintain the overall positive charge since K11 
was mutated to azide modified unnatural amino acid.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18. Scheme of cyclization and two mag2 variants with a triazole staple at different 
position 
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Figure 19.  Binding affinities and Lytic activities of linear and stapled mag2 against LUVs 
(POPC/POPG 1/1). (a) Dansyl fluorescence at 503 nm under the same condition. (b) Leakage of 
100 µM LUVs incubated with varying concentrations of peptides from 25 nM to 1.75 µM at 30 
°C for 2 hrs 
 
Binding affinities of peptide mutants were examined first based on dansyl 
fluorescence (Fig. 19a). For each peptide variant, the intensity at 503 nm is plotted versus 
peptide concentration. The similar intensity for each peptide at certain concentration 
indicated that all peptides have similar binding affinities.  
To evaluate the structural impact of installing a triazole staple into mag2, we 
conducted circular dichroism (CD) in PBS buffer as well as in SUVs (POPC/POPG 1/1) 
(Fig. 20). Mag2a and mag2a-1 were unstructured in aqueous solution as expected, while 
mag2a-2 was helical. It is conceivable that mag2a-2 forms a helical bundle in aqueous 
solution given its largest hydrophobicity, which affords increased hydrophobic 
interaction between peptide α-helices (Hydrophobicities of the peptides were evaluated 
a.	   b.	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  35	  
based on their retention times on reversed phase HPLC43 , 44 , table 3). A similar 
phenomenon was observed when fluorinated amino acids were incorporated into mag2, 
only the most hydrophobic mutant was significantly helical in aqueous solution. It turned 
out that stable helical bundles were formed, resulting in the lowest antimicrobial 
activity45. In PBS buffer, mag2a-1S showed significantly enhanced helicity compared to 
corresponding linear peptide mag2a-1, and mag2a-2S showed moderate improvement 
compared to mag2a-2. In SUVs solutions, mag2a-1S maintained the helicity 
enhancement over mag2a-1, however mag2a-2S had similar helicity with mag2a-2.  
Noticeably, all the CD measurements with membrane were done under the conditions 
(L/P 250/1) that all peptides were bound, thus the difference in helicity was exclusively 
caused by side-chain stapling effect. 
Table 3: Hydrophobicities and α  helicities of linear and stapled mag2 
α helicityb 
Peptide 
Sequence 
*=Nle, *=Pra 
tRa 
(min) PBS 
SUV
s 
Mag2a DNS-GIGKFLHSAKKFGKAFVGEIMNS-NH2 18.7 6% 60% 
Mag2a-1 (linear) DNS-GIGKFLHSAK*FGK*FVGQIMNS-NH2 20.5 9% 66% 
Mag2a-1S (cross-linked)  DNS-GIGKFLHSAK*FGK*FVGQIMNS-NH2 24.2 17% 85% 
Mag2a-2 (linear) DNS-GIGKFLHS*KKF*KAFVGEIMNS-NH2 25.8 20% 75% 
Mag2a-2S (cross-linked)  DNS-GIGKFLHS*KKF*KAFVGEIMNS-NH2 23.5 20% 75% 
aRetention times were determined by phase reversed HPLC. bValues obtained from circular dichroism 
spectroscopy studies. 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  43	  Tachi,T.; Epand,R.F.; Epand,R.M.; Matsuzaki,K. Biochemistry, 2002, 41, 10723-10731.  44	  Niemz, A.; Tirrell, D.A.	  J.Am.Chem.Soc. 2001, 123, 7407-7413 45	  Meng, H.; Kumar, K. J. Am. Chem. Soc. 2007, 129, 15615-15622 
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Figure 20.  Secondary structures of linear and stapled mag2. Circular dichroism spectra of (a) 
mag2a, mag2a-1, mag2a-1S, mag2a-2, mag2a-2S in PBS buffer, (b) 10 µM peptide incubated 
with 2.5 mM SUVs (POPC/ POPG 1/1).  
 
 
The membrane-lytic activities of these mag2 variants were then evaluated by 
Tb3+/DPA membrane leakage assay (Fig. 19b). EC50 was determined for each peptide 
a.	  
b.	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variant (table 4). Two linear precursors had similar membrane-lytic activities relative to 
the parent peptide mag2a, while two stapled peptides had increased activities, with 
improvements in EC50 values from 2 folds to almost 7 folds. At concentration as low as 
0.1 µM, the most potent variant mag2a-2S caused almost full leakage while mag2a and 
two linear precursors were not active at all. The trend of EC50 corresponded very well 
with the α helicities of these peptides on membrane, though with similar α helicities, 
mag2a-2S is 2-fold more active than mag2a-2. 
 
Table 4: EC50 and PC50 of the linear and stapled mag2 
Peptide EC50a (µM) PC50b (µM) 
Mag2a 0.61 ± 0.03 0.64 ± 0.02 
Mag2a-1 (linear) 0.67 ± 0.01 0.61 ± 0.03 
Mag2a-1S (cross-linked) 0.11 ± 0.01 0.17 ± 0.01 
Mag2a-2 (linear) 0.56 ± 0.02 0.56 ± 0.03 
Mag2a-2S (cross-linked) 0.27 ± 0.01 0.31 ± 0.01 
 
aThe EC50 values were extracted by extrapolation of the fitted curve to 50% lysis of POPC/POPG 1/1 
LUVs. bThe PC50 values were extracted by extrapolation of the fitted curve to 50% permanent pore 
formation of POPC/POPG 1/1 LUVs.  
 
Since we did not observe any difference in binding abilities, the increased 
membrane-lytic activity of stapled mag2 could only result from the increased membrane-
disturbing activities of the bound peptides.  
To characterize the effect of side-chain stapling on membrane disturbing ability, 
first of all, DLS was used to monitor the integrity of liposome going through the 
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membrane lysis, and no difference in vesicle size and dispersion implied that liposome 
vesicles were intact. Then we tested this set of mag2 variants with the same NBD 
fluorescence-quenching experiments used for photoswitchable mag2 variants to observe 
transient or permanent pore formation. This time the experiment was conducted under 
varied peptide concentrations.  
Surprisingly, we observed permanent pores formation with all our peptide 
variants through this method. With dithionite addition, different extents of inner leaflet 
NBD groups quenching were observed for samples with different peptide concentrations. 
Then transient pore formation could be excluded because NBD groups in the inner leaflet 
were only available for dithionite reduction with stable pores formed on the membrane. 
Thus the percentage of NBD groups quenched in the inner leaflet reflected the percentage 
of LUVs with stable pores on the membrane. If we plotted this value versus peptide 
concentration, we obtained PC50 for each peptide (Fig. 21). Perfect correlation between 
pores formation curve and membrane leakage curve indicated that membrane lysis is 
directly coupled with stable pores formation (Fig. 19b and Fig. 21). Therefore different 
lytic activity of mag2 variants actually came from different permanent pore formation 
abilities of the bound peptide molecules.  
Previous studies of H. Huang indicate stable pore formation only occurs when P/L 
reaches a threshold P/L*46,47. For AMPs they have studied (alamethicin, melittin, 
magainin and protegrin), the threshold concentration P/L* varies from 1/200 to ~1/10 
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  Huang,H.W. Biochim.Biophys.Acta, 2006, 1758, 1292-1302 
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(P/L~1/200 is the detectable limit of their experimental methods). Under our 
experimental conditions, the observed permanent pores formation at low P/L ratio of 
1/2000 for this set of mag2 variants indicates that the values of P/L* are significantly 
lowered down.  
Though our experimental results do not lead to a detailed structural description of 
these stable pores, we have proved that the increased α-helicity of mag2 in aqueous 
solutions as well as on membrane actually facilitates stable pore formation. Previous 
studies concerning the role of helicity in the antimicrobial effects utilized D-amino acid 
substitution to disturb helix formation. A systematic exchange of two neighboring 
residues in magainin by their D-enatiomers resulted in decreased helicity in the 
membrane-bound state and distinctly reduced its permeabilizing activity against neutral 
(POPC) and moderately negatively charged membrane (POPC/POPG 3/1) 48 , 49 . 
Investigation with a cationic amphipathic KLAL model peptide confirmed that the 
enhanced membrane disturbing ability is related to the size of the hydrophobic helix 
domain determined by the peptide helicity50.  
It is conceivable that a pre-organized α-helix in aqueous solution may help 
peptide to bind to membrane more easily. However, for mag2a, the measured apparent Kd 
is as high as 6 already (see Materials and Methods, Fig. S3), the enhancement might be 
undetectable under our experimental conditions, and it is not surprising that we didn’t 
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observe further improvement with side chain staple. For membrane permeabilization, a 
stabilized and rigidified α-helix on membrane may favor peptide insertion, 
intermolecular interaction, and further pore stabilization in the similar manner as 
discussed above. 
 
 
 
 
 
 
 
 
Figure 21.  Permanent pores formation of mag2 against POPC/POPG 1/1 LUVs. 100 µM 
LUVs incubated with varying concentrations of peptides from 25 nM to 1.75 µM at 30 °C for 2 
hrs, and dithionite was added (final concentration 10 mM). Fluorescence at 530 nm was 
monitored until the decrease reached the plateau and the ending point was used for calculation. 
 
With a closer look at the HC50 and PC50 for each peptide (table 4), we found out 
the enhancement of activity for mag2a-2S over mag2a-2 is only 2-fold compared to 7-
fold difference between mag2a-1S and mag2a-1. Because the triazole group is relatively 
hydrophilic, for mag2a-1S, the staple is accommodated well on the hydrophilic face, 
while for mag2a-2S this hydrophilic staple may not be preferred on the hydrophobic face. 
Antimicrobial activity and hemolytic activity were tested for each peptide variant. 
The antimicrobial activity was assessed as a minimal inhibitory concentration (MIC) 
using turbidity assays against both Gram-negative (E. Coli) and Gram-positive (B. 
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subtilis) bacteria (Table 5).  All other peptide variants had better or similar antimicrobial 
activities compared to mag2a with the exception of mag2a-1. Given that the most active 
members of the antimicrobial host defense peptides have MICs in the range 1~3 µM51,52, 
our peptides are already working at the potency limit, thus it is not surprising stapled 
mag2a show the same efficacy. Mag2a-1 was 16- and 2-fold less active against E. Coli 
and B. subtilis compared to other mag2 peptides. A pair of charged residues has been 
eliminated from mag2a-1, which may impede the diffusion of peptides into bacteria. On 
the other respect, mag2a-1S was 16- and 2-fold more active than mag2a-1 even with the 
same sequence, suggesting that stapling may also work for microorganism as well as 
artificial liposome system.  
 
aMICs represent at least two independent experiments, each in duplicate, and are reported as the highest 
determined values. bThe HC50 values were extracted by extrapolation of the fitted curve to 50% lysis of 
hRBCs 
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  Porter,E.A.; Weisblum,B.; Gellman,S.H. J.Am.Chem.Soc., 2005, 127, 11516-11529. 	  52	  Tossi,A.; Sandri,L.; Giangaspero,A. Biopolymers, 2000, 55, 1, 4-30	  
Table 5: Antimicrobial and Hemolytic Activities of the Peptides 
MICa (µg/ml) 
Peptide 
E. Coli B. subtilis 
HC50b (µg/ml) 
Mag2a 4 4 43 
Mag2a-1 (linear) 64 8 18 
Mag2a-1S (cross-linked) 4 4 12 
Mag2a-2 (linear) 4 4 N/D 
Mag2a-2S (cross-linked) 4 2-4 N/D 
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The ability of the peptides to disrupt the membrane integrity of mammalian cells 
was interrogated by a hemolysis assay with fresh human red blood cells (table 5). All 
peptide variants had increased hemolytic activity compared to mag2a, correlating with 
increased hydrophobicities.  
 
 
2.4.3 Conclusions 
To conclude, stapled mag2 showed significant enhancement in membrane-lytic 
activity in comparison with an unstapled one, and this facilitates stable pore formation in 
the membrane. For the first time, we have modified the on-membrane activity rather than 
binding affinity of mag2 by installing a staple into alpha-helical structure, which provides 
new insights into designing highly potent antimicrobial peptides. Additionally, to achieve 
maximal stabilization and thus highly potent mag2, we may incorporate a longer and 
more rigidified staple that can bridge sites far apart in amino acid sequence such as i, i+7 
or even i, i+11. Staples with varied physical properties may also be interesting if we can 
introduce different staple into different position of peptide sequence. For example, we 
may put a more hydrophobic staple than triazole on the hydrophobic face of mag2.   
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Chapter 3: Conclusion 
 In summary, our goal is to enhance the selective toxicity of AMPs by chemical 
modifications, including incorporation of the photoisomerizable moiety azobenzene and 
environment-responsive residue LHA. Also we have studied the effect of a side-chain 
staple on the membrane-lytic activity of AMPs. Through these studies, we have gained 
useful information that may lead us to a better understanding of their mechanisms of 
actions, and shed a light on the future design and engineering AMPs as the novel 
antibiotic alternatives. 
Development of mag2 with photo-switchable membrane-lytic activity has been 
achieved by incorporation of a photoisomerizable moiety azobenzene. Mechanistic 
studies suggest that the length of side chain plays an important role in the membrane-
disturbing ability of mag2.  In the second project, we tried to create a ‘smart’ mag2 only 
responsive to negatively charged membrane by incorporation of an environment-
responsive LHA group. We got very limited success primarily due to the unexpected 
impact of negatively charged membrane on the pKa of this environment-responsive 
residue. We sacrificed bound peptide membrane-disturbing ability for increased 
difference in binding affinity, and eventually, we got only 2-fold increase in selectivity. 
However, incorporation of a side-chain staple into LHA carrying mag2 may help it to 
fold into the right structure and enhance function. Stapled mag2 showed significantly 
enhancement in membrane-disturbing ability in comparison with unstapled mag2 due to 
facilitated stable pores formation by stabilized α-helix on membrane.  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  44	  
AMPs provide an attractive platform to develop novel antibiotics because of their 
rapid-acting and special mechanisms of action. Through the fine-tuning of AMPs, 
specific antimicrobial and biological effects could be obtained such as specificity, 
stability, and toxicity. Here we present different strategies with the hope to apply them 
generally into other AMPs besides mag2 and use them widely as effective tools to 
explore their mechanism of action, and eventually, achieve the goal of developing a safe 
and effective therapeutic method to treat bacteria infections.  
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Materials and Methods 
 
I. Materials and General Methods 
N-Fmoc-p-amino-phenylalaine, Fmoc-Dap(Alloc)-OH and Boc-Phe(4-I)-OH were 
purchased from Chem-Impex International. Inc (Wood Dale, IL). All other Fmoc-
protected amino acids were purchased from Advanced Chemtech (Louisville, KY). 1-
palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine (POPC), 1-palmitoyl-2-oleoyl-sn-
glycero-3-phospho- (1’-rac-glycerol) sodium salt (POPG), 1-­‐palmitoyl-­‐2-­‐oleoyl-­‐sn-­‐glycero-­‐3-­‐phosphoethanolamine (POPE) were obtained from Avanti Polar Lipids 
(Alabaster, AL). Dansyl chloride and phenylsliane was purchased from Acros Organics 
(Geel, Belgium). All other chemical reagents were purchased from Sigma-Aldrich 
(Milwaukee, WI). Fmoc-OSu, Rink-Amide-MBHA resin, Fmoc-Ser(tBu)-Wang resin 
and O-Benzotriazole-N,N,N’,N’-tetramethyl-uroniumhexafluoro-phosphate (HBTU) 
were purchased from Novabiochem (San Diego, CA).Peptide synthesis was carried out 
on a Tribute peptide synthesizer (Protein Technologies, Tucson, AZ). 1H NMR and 13C 
NMR data were collected on a Varian Gemini 400MHz NMR or Varian 500 MHz 
spectrometers. HR-MS data were generated by Boston College Mass-Spec facilities. 
Circular Dichroism measurements were performed on an Aviv 420 spectrometer 
(Biomedical, Inc., Lakewood, NJ). The protein concentration of all samples used in this 
study was determined by measuring their absorption on a Lambda 25 UV-Vis 
spectrometer (PerkinElmer, Waltham, MA). The extinction coefficient ε (330 nm) used 
for F12PAP-Mag2, F5DNS-F12PAP-Mag2, and F5W-F12PAP-Mag2 was 22387 cm-1M-
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1, 27687 cm-1M-1, 22387 cm-1M-1 respectively. For F5DNS-F12terphenyl-mag2, ε (280 
jjnm) = 33800 cm-1M-1 and for other DNS incorporated peptides, ε = 4300 cm-1M-1. The 
LUVs were prepared by using Liposofast Mini Extrusion System (Avanti Polar Lipids, 
Alabaster, Alabama). Fluorescence measurements were all performed on a Fluorolog-3 
fluorometer (Jobin Yvon Inc. Edison, NJ). Dynamic Light Scattering was performed on a 
DynaPro NanoStar (Wyatt Technology, Santa Barbara, CA). 
 
II. Synthesis 
(1) Preparation of Fmoc-phenylazophenylalanine-OH (Fmoc-PAP-OH) 
Synthesis of Fmoc protected PAP was carried out via a modified procedure by 
Borisenko53 et at. N-Fmoc-p-amino-phenylalaine (50 mg, 0.124 mmole) was dissolved in 
minimum amount of glacial acetic acid (5.5 mL). 3 equiv of nitrosobenzene (53 mg, 0.5 
mmole) was added in and the mixture was stirred at room temperature overnight. The 
reaction mixture was then quenched with saturated sodium bicarbonate (15 mL) and 
extracted with ethyl acetate (3×30 mL). The combined organic layers was then dried with 
anhydrous Na2SO4 and concentrated on a rotary evaporator. The crude product was then 
purified by silica gel column chromatography (CH2Cl2/MeOH 9/1). The final product 
was obtained as an orange solid (55 mg, 90%); ESI+: MH+ C30H26N3O4, calcd 492.1923, 
found 492.14636. 
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(2) Preparation of (S)-3-([1,1':4',1''-terphenyl]-4-yl)-2-((tert-
butoxycarbonyl)amino)propanoic acid (Boc-terphenyl-OH) 
 
Scheme S1. Synthesis of Boc-terphenyl-OH 
 (S)-2-(tert-butoxycarbonylamino)-3-(4-iodophenyl) propanoic acid (500 mg), biphenyl-
4-ylboronic acid (304 mg, 1.2 equiv.), Pd(PPh3)2Cl2 (45 mg, 0.05 equiv.), PPh3 (67 mg, 
0.2 equiv.) and K2CO3 (353 mg, 2.0 equiv.) were mixed in a pressure vial. Under N2 
protection, 30 mL DME and 5 mL H2O were added to dissolve all the solids and the 
resulting solution was sealed in the vial and stirred at 85 °C for ~1 hr.  1 N HCl was used 
to acidify the reaction to pH <1, and DCM was employed to extract the solution (3×). 
The combined organic layerS were washed with brine, dried over anhydrous Na2SO4, 
filtered, and the solvent was evaporated under vacuum. The crude product was purified 
by column chromatography on silica gel (toluene/HOAc 9/1) to afford the desired 
product (65%). 1H NMR (500 MHz, Methanol–d4) δ: 7.01-7.70 (m, 13H), 4.32 (m, 1H), 
3.18 (m, 1H), 2.82 (m, 1H), 1.37 (s, 9H). 
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(3) Preparation of (S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-([1,1':4',1''-
terphenyl]-4-yl)propanoic acid (Fmoc-terphenyl-OH) 
 
Scheme-S2. Synthesis of Fmoc-terphenyl-OH 
Boc-terphenyl-OH (203 mg) was dissolved in 12 mL TFA/Et3SiH mixture. After stirring 
at room temperature for 0.5 hr, the solvent was evaporated under vacuum. Then 20 mL of 
10% Na2CO3 and 12 mLCH3CN was used to dissolve the residue, with Fmoc-OSu (148 
mg, 0.9 equiv.) addition. The mixture was stirred vigorously at room temperature for 2.5 
hrs. The reaction was quenched with 2 N HCl and extracted with DCM (3×). The 
combined organic layers were dried over Na2SO4, filtered, and concentrated under 
vacuum. The crude material was purified by flash column chromatography on silica gel 
(Toluene/HOAc 15/1) to give the desired product as a white solid (90%). 1H NMR (500 
MHz, Chloroform–d) δ: 7.77 (d, J = 7.5 Hz, 2H), 6.84-7.66 (m, 19H), 4.42 (m, 1H), 3.25 
(m, 1H), 3.10 (m, 1H). 
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(4) Preparation of (S)-methyl 2-(tert-butoxycarbonylamino)-4-(tosyloxy)butanoate 
 
 
 
Scheme S3. Synthesis of (S)-methyl 2-(tert-butoxycarbonylamino)-4-(tosyloxy)butanoate 
 (S)-2-amino-4-hydroxybutanoic acid (1.0 g) was suspended in a solution of 2.93 mL (2.0 
equiv.) N, N-Diisopropylethylamine in 60 mL acetone/CH3OH (9:1). Then Di-tert-butyl 
dicarbonate (2.02 g, 1.1 equiv.) was added in portions. The resulting mixture was stirred 
at room temperature for 16 hrs. All solvents and excess reagent were removed under 
vacuum, and the obtained white solid was directly used in the next step. To a slurry of 
this compound in 50 mL THF was added (1.9 mL, 1.3 equiv.) N, N-
Diisopropylethylamine, followed by an addition of (1.05 mL, 2.0 equiv.) CH3I. The 
resulting mixture was stirred at room temperature overnight. The solvent was removed 
under vacuum and the residue was treated with 1 N HCl solution, and then extracted with 
EtOAc three times. The combined organic layers were washed with brine, dried over 
Na2SO4, filtered, and concentrated to afford a crude material that was used directly in the 
following step. DMAP (26 mg, 0.1 equiv.) was added to a solution of 500 mg crude 
material, p-Toluenesulfonic anhydride (841mg, 1.2 equiv.) and 486 µl DIPEA in DCM at 
0 oC. After the resulting mixture was stirred at room temperature for 24 hrs, it was poured 
into 50 mL 1 N HCl solution, and extracted with DCM (3×). The combined organic 
layers were washed with brine, dried over Na2SO4, filtered, and concentrated. The crude 
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OH 1. Boc2O, DIPEA, H2O/CH3CN, rt
2. CH3I, DIPEA, THF
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product was then purified with silica gel column (hexane/Et2O 1/1) to yield a colorless 
crystal (combined yield 40%). 1H NMR (500 MHz, Chloroform–d) δ: 7.78 (d, J = 6.5 Hz, 
2H), 7.36 (d, J = 9.0 Hz, 2H), 5.17 (d, J = 8.5 Hz, 2H), 4.33 (m, 1H), 4.11 (m, 2H), 3.71 
(s, 3H), 2.45 (s, 3H), 2.21 (m, 1H), 2.11 (m, 1H), 1.42 (s, 9H).  
 
 
 
(5) Preparation of (S)-methyl 2-((tert-butoxycarbonyl)amino)-4-((2,6-
dimethylpyridin-4-yl)oxy)butanoate 
 
 
 
Scheme S4. Synthesis of (S)-methyl 2-((tert-butoxycarbonyl)amino)-4-((2,6-dimethylpyridin-
4-yl)oxy)butanoate (Boc-LHA-COOMe) 
 
 (S)-methyl 2-(tert-butoxycarbonylamino)-4-(tosyloxy)butanoate (100 mg), Cs2CO3 
(168mg, 2.0 equiv.) and 2,6-dimethylpyridin-4-ol (54 mg, 1.7 equiv.) were mixed in 10 
mL CH3CN, and the resulting mixture was stirred at room temperature for 4 hrs. The 
reaction was treated with a mixture of saturated NaHCO3 solution and water to pH > 9, 
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and extracted with DCM (3×). The combined organic layers were washed with brine, 
dried over Na2SO4, filtered, and concentrated under vacuum. The crude material was 
purified by flash column chromatography on silica gel (EtOAc) to give the desired 
product (92%). 1H NMR (500 MHz, Chloroform–d) δ: 6.46 (s, 2H), 5.31 (d, J= 6.0 Hz, 
1H), 4.50 (m, 1H), 4.07 (t, J= 6.0 Hz, 2H), 3.77 (s, 3H), 2.46 (s, 6H), 2.33 (m, 1H), 2.23 
(m, 1H), 1.44 (s, 9H).  
 
 
(6) Preparation of (S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-4-(2,6-
dimethylpyridin-4-yloxy)butanoic acid (Fmoc-LHA-OH) 
 
 
 
 
Scheme S5. Synthesis of Fmoc-LHA-OH 
(S)-methyl 2-((tert-butoxycarbonyl)amino)-4-((2,6-dimethylpyridin-4-yl)oxy)butanoate 
(72 mg) was dissolved in 1 mL THF, then 3 mL H2O and LiOH•H2O (45 mg, 5.0 equiv.) 
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were added. The resulting solution was stirred at room temperature for 36 hrs. 1 N HCl 
was added to tune the pH to 5-7, and all solvents were removed under vacuum. 5 mLTFA 
and 250 µL Et3SiH were then added to the residue and stirred at room temperature for 2 
hrs. Solvents were then removed under vacuum, and the residue was treated with 4 mL 
10% Na2CO3 solution and 2mL CH3CN, then Fmoc-OSu (65 mg, 0.9 equiv.) was added. 
The resulting mixture was stirred at room temperature vigorously for 2.5 hrs. The 
reaction was quenched with 15 mL 1 N HCl solution and extracted with DCM (6×). The 
combined organic layers were dried over Na2SO4, filtered, and concentrated. The crude 
product was obtained through column chromatography purification on silica gel as a 
yellow oil (90%). 1H NMR (500 MHz, Methanol–d4) δ: 7.78 (d, J = 7.5 Hz, 2H), 7.66 (m, 
2H), 7.41 (m, 2H), 7.32 (m, 2H), 7.30 (s, 2H), 4.29-4.48 (m, 5H), 4.11 (m, 1H), 2.6 (s, 
6H), 2.47 (m, 1H), 2.23 (m, 1H). 
 
 
(7) Preparation of (S)-methyl 2-acetamido-4-(2,6-dimethylpyridin-4-yloxy)butanoate 
 
 
Scheme S6. Synthesis of (S)-methyl 2-acetamido-4-(2,6-dimethylpyridin-4-yloxy)butanoate 
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 (S)-methyl 2-((tert-butoxycarbonyl)amino)-4-((2,6-dimethylpyridin-4-yl)oxy)butanoate  
(150 mg ) were dissolved in 8 mL TFA and 0.4 mL Et3SiH, and the resulting mixture was 
stirred at room temperature for 2.5 hrs. The solvent was removed under vacuum and a 
mixture of saturated NaHCO3 solution and water was added to tune the pH to 5-7. Acetic 
anhydride (63 µL, 1.5 equiv.) was added then and the resulting solution was stirred at 
room temperature overnight. 10% Na2CO3 was employed to tune the pH to 10-12 and 
DCM was used for extraction (3×). The combined organic layers were dried over 
Na2SO4, filtered, and concentrated. The crude product was obtained through column 
chromatography purification on silica gel (DCM/Methanol 9/1) as a colorless oil (92%). 
1H NMR (500 MHz, Chloroform–d) δ: 6.44 (s, 2H), 4.76 (m, 1H), 4.05 (m, 2H), 3.77 (s, 
3H), 2.47 (s, 6H), 2.39 (m, 1H), 2.27 (m, 1H), 2.04 (s, 3H). 13C NMR (100 MHz, 
Chloroform–d) δ: 172.5, 170.2, 159.2, 106.6, 63.7, 52.6, 50.0, 31.2, 24.4, 23.0. HRMS 
(ESI+): m/z calculated for C14H21N2O4 [M]+, 281.15013; found 281.15080.	  
 
 
(8) Preparation of 4-(dodecyloxy)-2,6-dimethylpyridine 
 
Scheme S7. Synthesis of 4-(dodecyloxy)-2,6-dimethylpyridine 
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2,6-dimethylpyridin-4-ol (123 mg), dodecyl 4-methylbenzenesulfonate (343 mg, 1.2 
equiv.) and DIPEA  (258mg, 2.0 equiv.) were mixed in 10 mL CH3CN. After the 
resulting solution was refluxed overnight, all the solvent was evaporated under vacuum. 
The residue was resuspended in 10% Na2CO3 solution and extracted with DCM (3×). The 
combined organic layers were dried over anhydrous Na2SO4, filtered, and evaporated 
under vacuum. The crude material was purified through flash column chromatography on 
silica gel (EtOAc) to yield the desired product as a colorless liquid (80%). 1H NMR (500 
MHz, Chloroform–d) δ: 6.48 (s, 2H), 3.95 (t, J=6.5Hz, 2H), 2.46 (s, 6H), 1.78 (m, 2H), 
1.42 (m, 2H), 1.26 (m, 16H), 0.88 (t, J=7.0Hz, 3H). 13C NMR (100 MHz, Chloroform–d) 
δ: 158.9, 106.5, 67.5, 31.8, 29.5, 29.5, 29.5, 29.4, 29.2, 29.2, 29.1, 28.9, 26.0, 24.4, 22.6, 
14.0. HRMS (ESI+): m/z calculated for C19H34N1O1 [M]+, 292.26404; found 292.26525.	  
 
(9) Preparation of NBD-POPE 
The synthesis of NBD-POPE was performed according to a published procedure54 except 
that NBD-F was used instead of NBD-Cl. The obtained product (quantitative yield) was 
dissolved in anhydrous chloroform and kept at -30°C. 
 
(10) Preparation of Fmoc-Nle (εN3)-OH 
Fmoc-Nle (εN3)-OH was prepared from Fmoc-Lys-OH by a published method55. Sodium 
azide reacted with triflic anhydride to generate triflyl azide, which was directly used in 
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  Frazier, M.L.; Wright, J.R.; Pokorny, A.; and Almeida, P.F.F. Biophys. J. 2007, 92, 2422	  
55 Katayama, H.; Hojo, H.; Ohira, T.; Nakahara, Y. Tetrahedron Letters, 2008, 49, 5492-5494	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the copper (II)-catalyzed diazo transfer reaction with Fmoc-Lys-OH, leading to the final 
product as a off-white solid (84%). 
 
 
(11) Preparation of F12PAP-mag2&F5W-F12PAP-mag2 
Peptides were synthesized through Fmoc/tBu chemistry with the Fmoc-Ser (tBu)-Wang 
resin as the solid support. The synthesis was carried out on 0.05 mmole scale. Five 
equivalents of the commercially available amino acids as well as the synthetic PAP were 
used for the coupling reaction. The peptides were cleaved off the resin and deprotected 
with reagent K (80% TFA, 5% H2O, 2.5% EDT, 5% Thioanisole and 7.5% Phenol). The 
crude products were purified by RP-HPLC (Waters Prep LC, Jupiter 10u C4 300A 
Column). 
 
 
(12) Preparation of F5DNS-F12PAP-mag2 
Fmoc-Dap (Alloc)-OH and PAP were incorporated into the peptide sequence to replace 
the 5th and 12th phenylalanine respectively, following the same procedures as other 
natural amino acids did through Fmoc/tBu chemistry with the Fmoc-Ser (tBu)-Wang 
resin as the solid support. However, there was no N-terminal Fmoc group removal step, 
and the N-terminal glycine was introduced via an N-a-Boc-protected one in order to yield 
a free N-terminal a-amino group after final protecting group removal and resin cleavage. 
The Alloc deprotection was accomplished by addition of Pd (PPh3)4 (0.8 equivalent), 
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phenylsilane (25 equivalents) into the suspension of resin-bound peptide in dry CH2Cl2 
(30 mM in peptide), followed by shaking under nitrogen protection for 15min56. To 
guarantee the efficiency, the deprotection was repeated two additional times. Te dansyl 
residue was directly incorporated by reaction of the free amine (12.5 mM in DMF) with 
dansyl chloride (3 equivalents) and N, N-Diisopropylethylamine (6 equivalents) at room 
temperature stirring overnight. The peptides were cleaved off the resin and deprotected 
with reagent K (80% TFA, 5% H2O, 2.5% EDT, 5% Thioanisole and 7.5% Phenol). The 
crude products were purified by RP-HPLC (Waters Prep LC, Jupiter 10u C4 300A 
Column). 
(13) Preparation of F5DNS-F12Bipheyl-Mag2 & F5DNS-F12Terphenyl-Mag2 
These two peptides were synthesized by the same methods described in (6), except for 
the substitution at 12th phenylalanine was Fmoc-Ala (4,4’-biphenyl)-OH and Fmoc-
Terphenyl-OH respectively. 
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  Sainlos, M.; Imperiali, B. Nat. Protoc. 2007, 2, 3201.	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Scheme-S8. Synthesis of F5DNS-F12PAP-mag 2 
 
 (14) Preparation of N-DNS-mag2a, N-DNS-F12LHA-mag2a & N-DNS-TriLHA-
mag2a 
All peptides were synthesized on Rink-Amide-MBHA resin (90 mg, 0.56 mmol/g, 0.05 
mmol) using standard Fmoc/HBTU chemistry. Five equivalents of the commercially 
available amino acids were used for the coupling reaction. The incorporation of the LHA 
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moiety was accomplished by using three equivalents of the Fmoc-LHA-OH and extended 
coupling time (1 hour). After cleavage of the N-terminal Fmoc group from the fully 
protected peptide on resin, a dansyl residue was attached by the reaction of the N-
terminal amino group with dansyl chloride (40 mg, 0.15 mmol) in presence of DIPEA (52 mL, 0.30 mmol) overnight. The cleavage and purification steps were the same as other 
peptide synthesis described above. 
(15) Preparation of linear mag2a 
Linear precursor synthesis was carried out according to the same procedure in (9). For the 
azide and terminal alkynyl moiety incorporation, three equivalents of the Fmoc-Nle 
(εN3)-OH and Fmoc-propargylglycine (Pra) were used with an extended coupling time (1 
hr). The cleavage and purification steps were the same as other peptide synthesis 
described above. 
(16) Preparation of stapled mag2a 
Cyclization of the purified linear precursor was carried out under the condition published 
by Cantel et al.57, which employed 4.4 equivalents of CuSO4 and ascorbic acid with a 
peptide concentration of 1mg/ml in 2:1 H2O/t-BuOH. The reaction was monitored by 
analytical RP-HPLC.  The reaction went to a completion within 1 hr at room temperature. 
After the conversion was done, organic solvent was evaporated and the residue was 
lyophilized to afford the crude product, which then was resuspended and purified with 
RP-HPLC. 
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III Measurements 
(1) Vesicle preparation 
Lipids mixture with the desired compositions was dissolved in chloroform. The solution 
was dried under a high vacuum overnight. The lipid films were then dispersed in TES 
buffered solution (10 mM 2-[Tris(hydroxymethyl)methylamino]-1-ethanesulfonic acid, 
100 mM sodium citrate, pH = 7.0) to a final lipid concentration of 100 mM. The lipid 
suspension was freeze-thawed for 20 cycles and extruded through filters (20 times) 
whose pore size was 100 nm. The mean diameter of the LUVs was determined by 
dynamic light scattering to be 65-75 nm. SUVs for CD spectroscopy were prepared by 
sonication of the lipid suspension in buffer (10 mM Trizma, 150 mM NaCl, pH=7.0) 
using a titanium-tipped ultrasonicator. The lipid concentration was determined in 
triplicate based on complex formation between ammonium ferrothiocyanate and POPC 
according to stewart assay58. 
(2) Liposome leakage assay 
Tb3+ entrapped LUVs were prepared by hydrating a desired lipids mixture with Tb3+ 
solution (50 mM Tb3+, 10mM TES, 100 mM Sodium citrate, pH=7). After extrusion as 
described above, Tb3+ entrapped LUVs were separated from free Tb3+ on a Bio-Gel 
A1.5m column immediately. The release of Tb3+ from the LUVs formed Tb3+/DPA 
complex and was fluoremetrically monitored at an excitation wavelength of 270 nm and 
an emission wavelength of 489 nm at 25 oC. 
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Scheme S9. Tb3+/DPA complex based leakage assay 
 
Figure S1. Photoswitching modulates F5DNS-F12PAP-mag2 membrane permeabilization. 
This experiment was performed with 1 µM peptide and 500 µM LUVs made of POPC/POPG 1/1 
at room temperature with stirring.  
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Figure S2. EC50 determination of F5DNS-mag2, F5DNS-F12biphenyl-OH and 
F12terphenyl-OH. This experiment was performed with 500 µΜ LUVs (POPC/POPG 1/1) and 
varying concentrations of peptides. 
(3) CD spectroscopy 
CD measurements of all mag2 mutants were performed with peptides in the presence of 
SUVs (POPC: POPG=1:1) or 50% TFE in PBS buffer at room temperature. For each 
spectrum, three scans were accumulated and the baseline (SUVs without peptide) was 
subtracted. 
(4) Binding affinity assay 
The binding affinity of the peptides against the membrane was determined on the basis of 
dansyl fluorescence. Peptide solutions were incubated with various amounts of LUVs 
(POPC/POPG 1/1 or POPC) at 25 °C until no more change of dansyl fluorescence was 
observed. Fluorescence spectra in the range of 490-570 nm were recorded at an excitation 
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wavelength of 337 nm. The spectra were corrected by subtraction of corresponding blank 
spectra without the peptide. 
 
Figure S3. Binding affinity of mag2a towards LUVs POPC/POPG 1/1. This experiment was 
performed with 4 µΜ peptide and varying concentrations of lipids. 
 
(5) Peptide translocation measurement 
Peptide was incubated with LUVs at 30 oC for 2 hrs. For 2 µM peptide in 2 mL solution, 
14 mL of a trypsin solution (5 mg/mL in 1 mM HCl) was added to hydrolyze the peptide 
molecules located on the outer leaflet. The dansyl fluorescence was monitored and no 
more decrease at 505 nm was observed after 20 min. This value was recorded as Fm. 
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(6) NBD quenching assay 
 
 
 
 
 
 
 
 
 
 
Scheme S10. Fluorescence quenching assay 
(7) Antimicrobial Activity 
Antimicrobial activity was measured as Minimal Inhibitory Concentrations (MICs) 
against both Gram-negative Escherichia Coli (BL21) and Gram-positive Bacillus subtilis 
(ATCC 663) using broth microdilution method. Bacteria from a single colony were 
grown overnight in LB broth at 37 °C with agitation.  An aliquot was taken and diluted in 
fresh broth and cultured for another ∼ 2 hours until the cells reached mid-logarithmic 
phase (OD590 ∼ 0.5). The cells were then diluted to a concentration of ∼ 5 × 105 colony 
forming units/mL and 200 µL of the diluted solution was added to each well of a sterile 
96-well plate. 2 µL of serial dilution (2-fold) of peptides in DMSO were added in 
triplicate. The plate were mixed for 30 seconds, followed by incubation at 37oC for 18 
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hrs. The absorbance at 590 nm was monitored using a microtiter plate reader SpectraMax 
M5, Molecular Devices, Sunnyvale, CA). The MIC was recorded as the minimum 
concentration of peptides required for the complete inhibition of cell growth (no change 
in absorbance).  
(8) Hemolytic assay 
Fresh type B human blood cells (hRBCs) were centrifuged at 3500 rpm and washed with 
PBS buffer until the supernatant was clear. The hRBCs were then resuspended and 
diluted to a final concentration of 1% (v/v) in PBS and used immediately.  15 µL of serial 
dilution (2-fold) of peptides in DMSO or DMSO only as negative control was added to 
1.5 mL of hRBCs in PBS. The resulted mixture was gently shaken to mix well and 
incubated at 37 °C for 1 hr, followed by centrifugation at 3500 rpm for 10 min using 
tabletop centrifuge.  An aliquot (50 µL) of supernatant in triplicate was transferred to a 
sterile 96-well plate containing 50 µL of H2O in each well. Release of hemoglobin was 
monitored at 415 nm using a microtiter plate reader. Percentage hemolysis was calculated 
using percentage hemolysis = 100 • (A415, peptide- A415, DMSO)/ (A415, complete hemolysis- A415, 
DMSO), where complete hemolysis is achieved by mixing hRBCs with 1% TritonX-100.   
(9) pKa measurement  
The UV-Vis spectrum of LHA moiety differs at different pH: The maximum absorbance 
shifts from 238 nm to 225 nm when LHA switches from protonated form to depronated 
form. pKa of LHA moiety in PBS buffer was measured with  (S)-methyl 2-acetamido-4-
(2,6-dimethylpyridin-4-yloxy)butanoate 1. The concentration of 1 was 2 mM. The pH 
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was determined by a glass electrode (Thermal Fisher Scientific, Beverly, MA) relative to 
NBS standard solutions.  
 
 
 
Figure S4. pKa measurement of LHA in aqueous solution pKa	   of	   LHA	   moiety	   in	   membrane	   was	   measured	   with	   4-(dodecyloxy)-2,6-
dimethylpyridine 2 in micellar solutions of sodium dodecyl sulfate (SDS) and 
dodecylphosphocholine (DPC). The detergent concentrations were 20 mM for SDS and 
Triton X-100. The titration was performed in the presence of PBS buffer.  
 	  	  	  	  
   
                          
 
Figure S5. pKa measurement of LHA in membranes 
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Appendix 
 
Peptide Sequence 
F12PAP-mag2 GIGKFLHSAKK(PAP)GKAFVGEIMDS 
F5DNS-F12PAP-mag2 GIGK(DNS)LHSAKK(PAP)GKAFVGEIMDS 
F5W-F12PAP-mag2 GIGKWLHSAKK(PAP)GKAFVGEIMDS 
F5DNS-mag2 GIGK(DNS)LHSAKKFGKAFVGEIMDS 
F5DNS-F12Biphenyl-mag2 GIGK(DNS)LHSAKK(Bipheyl)GKAFVGEIMDS 
F5DNS-F12Terphenyl-mag2 GIGK(DNS)LHSAKK(Terphenyl)GKAFVGEIMDS 
N-DNS-mag2a DNS-GIGKFLHSAKKFGKAFVGEIMDS-NH2 
N-DNS-TriLoHoAla-mag2a DNS-GIGK(LHA)LHSAKK(LHA)GKA(LHA)VGEIMDS-NH2 
N-DNS-F12LoHoAla-mag2a DNS-GIGKFLHSAKK(LHA)GKAFVGEIMDS-NH2 
Mag2a DNS-GIGKFLHSAKKFGKAFVGEIMNS-NH2 
Mag2a-1 (linear) DNS-GIGKFLHSAK(Nle)FGK(Pra)FVGAIMNS-NH2 
Mag2a-1S (cross-linked) DNS-GIGKFLHSAK(Nle)FGK(Pra)FVGAIMNS-NH2 
Mag2a-2 (linear) DNS-GIGKFLHS(Nle)KKF(Pra)KAFVGEIMNS-NH2 
Mag2a-2S (cross-linked) DNS-GIGKFLHS(Nle)KKF(Pra)KAFVGEIMNS-NH2 
 
 
 
 
 
